Search research articles
Contact Us
Filters
Showing results (361-370 of 402) with videos related to
Page
of 41
Sort By:
Biochemical Pharmacology
|
September 14, 1999
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
J T Lim, G A Piazza, E K Han, et al.
Cancer Research
|
May 19, 2001
Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis
G A Piazza, W J Thompson, R Pamukcu, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 13, 2010
A high-throughput screen for chemical inhibitors of exocytic transport in yeast
Lisha Zhang, N Miranda Nebane, Krister Wennerberg, et al.
Annals of Human Genetics
|
January 31, 2003
Autosomal microsatellite and mtDNA genetic analysis in Sicily (Italy)
V Romano, F Calì, A Ragalmuto, et al.
Science Immunology
|
October 31, 2020
Persistent STAT5 activation reprograms the epigenetic landscape in CD4<sup>+</sup> T cells to drive polyfunctionality and antitumor immunity
Zhi-Chun Ding, Huidong Shi, Nada S Aboelella, et al.
Anticancer Research
|
August 15, 2001
Radioguided-surgery of early breast lesions
O Buonomo, A Cabassi, F Guadagni, et al.
Gastroenterology
|
December 12, 1997
A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes
N Arber, E K Han, A Sgambato, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity
Mohammad Abdel-Halim, Sara Sigler, Nora A S Racheed, et al.
Transplantation Proceedings
|
March 1, 1972
Joint report of first histocompatibility workshop on primates
H Balner, A D Barnes, J D'Amaro, et al.
Oncotarget
|
August 25, 2015
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
Nan Li, Xi Chen, Bing Zhu, et al.
Page
of 41
Search research articles
Search
Showing results (361-370 of 402) with videos related to
Sort By:
Page
of 41
Biochemical Pharmacology
|
September 14, 1999
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
J T Lim, G A Piazza, E K Han, et al.
Cancer Research
|
May 19, 2001
Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis
G A Piazza, W J Thompson, R Pamukcu, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 13, 2010
A high-throughput screen for chemical inhibitors of exocytic transport in yeast
Lisha Zhang, N Miranda Nebane, Krister Wennerberg, et al.
Annals of Human Genetics
|
January 31, 2003
Autosomal microsatellite and mtDNA genetic analysis in Sicily (Italy)
V Romano, F Calì, A Ragalmuto, et al.
Science Immunology
|
October 31, 2020
Persistent STAT5 activation reprograms the epigenetic landscape in CD4<sup>+</sup> T cells to drive polyfunctionality and antitumor immunity
Zhi-Chun Ding, Huidong Shi, Nada S Aboelella, et al.
Anticancer Research
|
August 15, 2001
Radioguided-surgery of early breast lesions
O Buonomo, A Cabassi, F Guadagni, et al.
Gastroenterology
|
December 12, 1997
A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes
N Arber, E K Han, A Sgambato, et al.
Journal of Medicinal Chemistry
|
April 1, 2021
From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity
Mohammad Abdel-Halim, Sara Sigler, Nora A S Racheed, et al.
Transplantation Proceedings
|
March 1, 1972
Joint report of first histocompatibility workshop on primates
H Balner, A D Barnes, J D'Amaro, et al.
Oncotarget
|
August 25, 2015
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
Nan Li, Xi Chen, Bing Zhu, et al.
Page
of 41